This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Pohang University of Science and Technology Foundation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Na Youn Won: Innovator in pH Sensitive Metal Nanoparticles
Introduction
Na Youn Won is a prominent inventor based in Pohang-si, South Korea. He has made significant contributions to the field of medical technology through his innovative research and development of pH sensitive metal nanoparticles. His work focuses on utilizing these nanoparticles for medical treatments, particularly in cancer therapy.
Latest Patents
Na Youn Won holds a patent for a pH sensitive metal nanoparticle and its preparation method. This invention relates to a pH sensitive particle, a method of preparation thereof, and its use in medical treatment. The pH sensitive metal nanoparticle consists of a ligand compound whose charge changes depending on the pH of the environment. This unique property allows the nanoparticles to be collected in cells, such as cancer cells, which present an abnormal pH environment. The invention enables the induction of cell death through a photothermal procedure after aggregation, making it a promising approach for cancer treatment.
Career Highlights
Na Youn Won is associated with the Postech Academy-Industry Foundation, where he continues to advance his research in the field of nanotechnology and medical applications. His work has garnered attention for its potential impact on cancer treatment methodologies.
Collaborations
He collaborates with notable colleagues, including Sung Jee Kim and Sang Hwa Jeong, who contribute to his research endeavors and help in the development of innovative solutions in the medical field.
Conclusion
Na Youn Won's contributions to the development of pH sensitive metal nanoparticles represent a significant advancement in medical technology. His innovative approach has the potential to enhance cancer treatment options and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile